Published on 27 Jul 2023 on Simply Wall St. via Yahoo Finance
G1 Therapeutics, Inc.'s (NASDAQ:GTHX) top owners are individual investors with 46% stake, while 38%...
Key Insights
Significant control over G1 Therapeutics by individual investors implies that the general public has more power to influence management and governance-related decisionsThe top 25 shareholders own 46% of the company 38% of G1 Therapeutics is held by Institutions
If you want to know who really controls G1 Therapeutics, Inc. (NASDAQ:GTHX), then you'll have to look at the makeup of its share registry. We can see that individual investors own the lion's share in the company with 46% ownership. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).